Please login to the form below

Not currently logged in
Email:
Password:

W2O taps Tom Richards as creative leader of 21GRAMS

Richards joins as co-global chief creative officer

Tom Richards

W2O has appointed Tom Richards as co-global chief creative officer of its healthcare firm 21GRAMS.

Richards joins 21GRAMS from global healthcare communications agency Havas Lynx, where he served as chief creative officer. During his time at Havas, he grew the creative department to over a 100 staff members, and led the company to win the Lions Health ‘Healthcare Agency of the Year’ in 2018.

Richards is also president of the Health and Wellness jury of the Cannes Lions Festival, a position he will continue in until 2021.

“Ask any agency in health, around the world, who would be on their wish list,” said 21GRAMS co-global chief creative officer, Frank Mazzola.

“Nine out of ten will say Tom Richards. The work he’s led consistently shows the industry what great looks like. Not just in ideas that break the norms of traditional advertising, but in craft. As someone who came up in copy, and Tom in art, we complement each other well,” he added.

W2O acquired 21GRAMS in January to broaden its advertising portfolio and elevate its overall offering in the healthcare industry. W2O, a leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, employs over 1,300 people in 18 offices across the US and in Europe.

“I have always admired 21GRAMS and its philosophy of finding what makes people tick, and creating work that really ‘gets’ them. Work that doesn’t just compete with other brands, but anything fighting for the audience’s attention,” said Richards.

“It’s not every day you get to be a part of, and help build, a new kind of health agency – one with a passion for creativity at its heart and soul. The leadership team has great chemistry and delights in doing things differently, and I’m thrilled to be a part of it,” he added.

17th July 2020

From: Marketing

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Parkinson’s disease: past, present and future
Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...